Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For urgent concerns, contact NHS 111
12.18.24 Study shows link between semaglutide use and NAION A December study showed that a once-weekly semaglutide doubles the five-year risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
In the semaglutide group, there was an improvement in quality of life according to the Kansas City Cardiomyopathy Questionnaire (KCCQ-CSS), with a mean change in KCCQ-CSS score of 13.7 points with semaglutide and 6.4 points with placebo (p 1% significantly decreased hospitalisations (aOR 1.33
[PMID: 31099885] PubMed record related to this compound for laboratory literature review
US$ 22.55
US$ 29.52
US$ 24.89
US$ 20.70
US$ 29.40
US$ 23.34
US$ 27.67
US$ 26.90
US$ 20.25
US$ 25.80
